Bacterial surface and secreted antigens (BSSA)

Bacterial surface and secreted antigens represent a broad and diverse category of molecules that are essential for the survival, colonization, and pathogenicity of bacteria within a host. Surface antigens, such as adhesins, pili, flagella, and capsular polysaccharides, are critical for the physical interaction between the bacteria and host cells, often facilitating attachment and biofilm formation (NCBI, 2021). Secreted antigens, including exotoxins and various enzymes, are released into the host environment to damage tissues, acquire nutrients, or actively suppress the host's immune response (PubMed, 2022). In the context of drug development, these antigens are the primary targets for vaccines and therapeutic monoclonal antibodies because they are highly accessible to the immune system. Vaccines work by priming the immune system to recognize these antigens, leading to the production of neutralizing antibodies and memory cells. Monoclonal antibodies, such as Bezlotoxumab, target specific secreted toxins to prevent their cytotoxic effects (FDA, 2016). While highly effective, targeting these antigens faces challenges such as high genetic variability among bacterial strains and the potential for bacteria to evolve escape mutants that no longer express the targeted epitope.

Other names

Bacterial antigensSurface-exposed proteinsSecreted virulence factorsExoproteinsOuter membrane proteinsBacterial toxins

Drugs and vaccines targeting these antigens function by neutralizing bacterial toxins, inhibiting bacterial adhesion to host tissues, or promoting opsonophagocytosis and complement-mediated killing of the pathogen.